Professional tennis player Nick Kyrgios has been suspended from the sport after testing positive for cocaine [1].
The suspension removes one of the tour's most prominent and polarizing figures from competition. This development raises questions about the consistency of anti-doping enforcement across the professional circuit.
The International Tennis Federation's anti-doping authority announced the result on Aug. 19, 2026 [1]. According to reports, a routine anti-doping test returned a positive result for cocaine [2]. Cocaine is listed as a prohibited substance under the current tennis anti-doping rules [2].
Kyrgios has a history of volatile behavior on and off the court, but this marks his first major suspension for a banned substance. The announcement came via the federation's governing body, though the specific location where the test was administered was not disclosed [2].
The timing of the suspension disrupts the player's current season and standing within the professional rankings. Anti-doping authorities typically follow a strict protocol for prohibited substances, which can lead to varying lengths of suspension depending on the circumstances of the use [2].
While Kyrgios has not yet provided a public detailed defense, the positive test result triggers an automatic review process. The federation's rules mandate that any player testing positive for a prohibited substance must be removed from competition until the legal and medical review is complete [1].
“Nick Kyrgios has been suspended from the sport after testing positive for cocaine.”
This suspension highlights the rigorous nature of the International Tennis Federation's anti-doping program, which applies to all players regardless of their star power. Because cocaine is categorized as a prohibited substance, the federation must act to maintain the integrity of the sport, likely resulting in a significant period of inactivity for Kyrgios that could impact his career trajectory and sponsorship deals.
